Production of Procalcitonin (PCT) in Non-Thyroidal Tissue after LPS Injection

 

 Buy Article Permissions and Reprints

Abstract

Procalcitonin (PCT) is one of the precursors in the synthesis of calcitonin in thyroidal C-cells and other neuroendocrine cells. PCT, among other calcitonin precursors, is elevated in the serum of many conditions associated with a systemic inflammatory response syndrome, even in the absence of the thyroid gland. The aim of our study was to identify PCT-producing extrathyroidal tissues in primate sepsis. In order to induce PCT production, we treated four olive baboons (papio cynocephalus anubis) with the endotoxin lipopolysaccharide (LPS) from s. typhimurium. We found an increase in serum PCT 3 to 5 hours after LPS injection to levels of 0.2 ng/ml, attaining a peak above 4 ng/ml PCT at 10 hours. In contrast, the untreated baboon had no detectable circulating PCT in the serum. In one animal, additional LPS boosting after 24 hours did not increase serum PCT further. Soluble proteins were extracted from different organs, fractionated by C18 extraction, and PCT was measured in an immunoluminometric assay (ILMA), which was specifically developed for this study. PCT concentrations above 0.2 ng/g of wet tissue were found in a variety of organs in LPS treated baboons, but not in the control baboon. Organs and tissues with the highest PCT concentration included liver, kidney, aorta, fat, ovaries, bladder and adrenal gland. RT-PCR confirmed an extrathyroidal origin of PCT. Importantly, CT-mRNA expression was found in liver, lung, kidney, adrenal, colon, skin, spleen, brain and pancreas. In conclusion, our data confirm previous findings in hamsters, indicating an extrathyroidal origin for PCT in sepsis. Our primate model offers a valuable tool for further investigation of PCT's pathophysiological role and its immunoneutralization as a therapy for sepsis.

References

• 1 Snider R H, Nylen E S, Becker K L. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization.  J Investig Med. 1997;  45 552-560
  PubMedGoogle Scholar
• 2 Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection.  Lancet. 1993;  341 515-518
  CrossrefPubMedGoogle Scholar
• 3 Rau B, Steinbach G, Gansauge F, Mayer J M, Grunert A, Beger H G. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis.  Gut. 1997;  41 832-840
  CrossrefPubMedGoogle Scholar
• 4 Brunkhorst F M, Eberhard O K, Brunkhorst R. Early identification of biliary pancreatitis with procalcitonin [letter].  Am J Gastroenterol. 1998;  93 1191-1192
  PubMedGoogle Scholar
• 5 Nylen E S, O’Neill W, Jordan M H, Snider R H, Moore C F, Lewis M, Silva O L, Becker K L. Serum procalcitonin as an index of inhalation injury in burns.  Horm Metab Res. 1992;  24 439-443
  PubMedGoogle Scholar
• 6 Mimoz O, Benoist J F, Edouard A R, Assicot M, Bohuon C, Samii K. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome.  Intensive Care Med. 1998;  24 185-188
  CrossrefPubMedGoogle Scholar
• 7 Gendrel D, Assicot M, Raymond J, Moulin F, Francoual C, Badoual J, Bohuon C. Procalcitonin as a marker for the early diagnosis of neonatal infection.  J Pediatr. 1996;  128 570-573
  PubMedGoogle Scholar
• 8 Whang K T, Steinwald P M, White J C, Nylen E S, Snider R H, Simon G L, Goldberg R L, Becker K L. Serum calcitonin precursors in sepsis and systemic inflammation.  J Clin Endocrinol Metab. 1998;  83 3296-3301
  CrossrefPubMedGoogle Scholar
• 9 Muller B, Becker K L, Schachinger H, Rickenbacher P R, Huber P R, Zimmerli W, Ritz R. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit.  Crit Care Med. 2000;  28 977-983
  CrossrefPubMedGoogle Scholar
• 10 Nylen E S, Whang K T, Snider R H, Steinwald P M, White J C, Becker K L. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.  Crit Care Med. 1998;  26 1001-1006
  PubMedGoogle Scholar
• 11 Martinez J M, Wagner K E, Snider R H, Nylen E S, Muller B, Sarani B, Becker K L, White J C. Late immunoneutralization of procalcitonin arrests the progression of lethal porcine sepsis.  Surgical Inf. 2002;  2 193-201
  PubMedGoogle Scholar
• 12 Muller B, Becker K L, Kranzlin M, Schachinger H, Huber P R, Nylen E S, Snider R H, White J C, Schmidt-Gayk H, Zimmerli W, Ritz R. Disordered calcium homeostasis of sepsis: association with calcitonin precursors.  Eur J Clin Invest. 2000;  30 823-831
  CrossrefPubMedGoogle Scholar
• 13 Muller B, White J C, Nylen E S, Snider R H, Becker K L, Habener J F. Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis.  J Clin Endocrinol Metab. 2001;  86 396-404
  CrossrefPubMedGoogle Scholar
• 14 Dandona P, Nix D, Wilson M F, Aljada A, Love J, Assicot M, Bohuon C. Procalcitonin increase after endotoxin injection in normal subjects.  J Clin Endocrinol Metab. 1994;  79 1605-1608
  CrossrefPubMedGoogle Scholar
• 15 Wrenger S, Kahne T, Bohuon C, Weglohner W, Ansorge S, Reinhold D. Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV).  FEBS Lett. 2000;  466 155-159
  CrossrefPubMedGoogle Scholar
• 16 Stahl W R. Organ weights in primates and other mammals.  Science. 1965;  150 1039-1042
  CrossrefPubMedGoogle Scholar
• 17 Gunther B. Dimensional analysis and theory of biological similarity.  Physiol Rev. 1975;  55 659-699
  PubMedGoogle Scholar
• 18 Becker K L, Müller B, Nylen E, Cohen R, Silva O, Snider R. Calcitonin gene family of peptides. In: Becker KL (ed) Principles and Practice of Endocrinology and Metabolism. Philadelphia; J.B. Lippincott 2001: 520-534
  Google Scholar
• 19 Kiriyama Y, Nomura Y, Tokumitsu Y. Calcitonin gene expression induced by lipopolysaccharide in the rat pituitary.  Am J Physiol Endocrinol Metab. 2002;  282 E1380-1384
  PubMedGoogle Scholar
• 20 Weglohner W, Struck J, Fischer-Schulz C, Morgenthaler N G, Otto A, Bohuon C, Bergmann A. Isolation and characterization of serum procalcitonin from patients with sepsis.  Peptides. 2001;  22 2099-2103
  CrossrefPubMedGoogle Scholar
• 21 Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, Jager L, Reinhart K. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro.  J Lab Clin Med. 1999;  134 49-55
  CrossrefPubMedGoogle Scholar
• 22 Monneret G, Laroche B, Bienvenu J. Procalcitonin is not produced by circulating blood cells.  Infection. 1999;  27 34-35
  PubMedGoogle Scholar
• 23 Bernard L, Ferriere F, Casassus P, Malas F, Leveque S, Guillevin L, Lortholary O. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults.  Clin Infect Dis. 1998;  27 914-915
  PubMedGoogle Scholar
• 24 Redl H, Schlag G, Togel E, Assicot M, Bohuon C. Procalcitonin release patterns in a baboon model of trauma and sepsis: relationship to cytokines and neopterin.  Crit Care Med. 2000;  28 3659-3663
  PubMedGoogle Scholar
• 25 Volk H D, Reinke P, Krausch D, Zuckermann H, Asadullah K, Muller J M, Docke W D, Kox W J. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis.  Intensive Care Med. 1996;  22 Suppl 4 S474-481
  CrossrefPubMedGoogle Scholar

Dr. N. G. Morgenthaler

Research Department · B.R.A.H.M.S AG

Neuendorfstrasse 25 · 16761 Hennigsdorf/Berlin

Phone: + 49 (33) 02-883-450

Fax: + 49 (33) 02-883-451 ·

Email: n.morgenthaler@brahms.de